SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Space Exploration Technologies Corp. engages in the design, manufacture, and launch of rockets and spacecrafts. It provides satellite communication services. The company was founded by Elon Reeve Musk on March 14, 2002 and is headquartered in Hawthorne, CA.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is dominating market conversation following its historic IPO, with traders divided between FOMO-driven buying and warnings that the stock is severely overvalued compared to its current earnings. While many investors are positioning for long-term growth as part of the broader space economy, others are treating the debut as a highly volatile scalp play and speculating on an inevitable pullback as institutional liquidity rotates into the name.

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

Destiny Tech 100 is experiencing heightened volatility as investors weigh its role as a proxy for SpaceX against concerns regarding dilution and the potential for a scarcity premium to evaporate following the SpaceX IPO. While the community remains divided between those viewing the fund as a strategic, value-oriented play for pre-IPO access and those frustrated by recent price action, active discussion is dominated by debates over updated NAV calculations and the impact of the ongoing ATM offering.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is currently trending as investors weigh the impact of the high-profile SpaceX debut alongside its own recent inclusion in the Nasdaq-100 index. Community discourse is sharply divided between those who believe the broader space sector is undergoing a massive structural revaluation and those who fear that speculative capital is rotating out of secondary proxies and into SpaceX, creating short-term volatility.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is currently trending due to a significant double-upgrade by Bank of America, which boosted sentiment around the company's CPU demand and foundry visibility in the AI sector. The community is actively debating the stock's potential as a long-term play, closely monitoring support levels near the 110-125 range while discussing its strategic partnerships and involvement in large-scale AI infrastructure projects.

Tema ETF Trust - Tema Space Innovators ETF

Tema Space Innovators ETF

The Tema Space Innovators ETF is seeing intense volatility as investors rotate capital ahead of the SpaceX IPO, with community sentiment divided between those treating the pullback as a buying opportunity and others fearing a 'sell-the-news' event. Traders are actively debating how the ETFs unique pre-IPO exposure to SpaceX will be valued once the stock begins trading publicly.

EchoStar Corp. engages in the design, development, and distribution of digital set-top boxes and products for direct-to-home satellite service providers. It operates through the following business segments: Pay-TV, Retail Wireless, and Broadband and Satellite Services. The Pay-TV segment business strategy is to be the best provider of video services in the United States by providing products with the best technology, outstanding customer service, and great value. The Retail Wireless segment offers Retail Wireless services as well as a competitive portfolio of wireless devices. The Broadband and Satellite Services segment business strategy is to maintain and improve leadership position and competitive advantage through development of technologies and services marketed to selected sectors within the consumer, enterprise and government markets globally. The company was founded by Charlie William Ergen, Candy Ergen, and James DeFranco in 1980 and is headquartered in Englewood, CO.

EchoStar Corp - Ordinary Shares - Class A

EchoStar Corp

EchoStar is currently trending as investors look for indirect exposure to SpaceX through its equity stake, with heavy trading volume fueled by speculative rotation and anticipation of the IPO. Community discussion is sharply divided between bullish expectations for a short squeeze and structural upside, and skepticism driven by concerns over the company's debt load and the mechanics of the SpaceX spectrum deal.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk is currently trending as the community debates a potential turning point following the resolution of a fee dispute with Publicis. While some investors view the settlement as a catalyst for a short squeeze and long-term recovery, others remain skeptical, citing persistent negative sentiment, executive turnover, and the stock's inability to maintain momentum.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is facing significant selling pressure as investors grapple with a leadership vacuum following the sudden departure of its CFO, despite the company delivering a solid earnings beat and raised full-year guidance. Community discussions are heavily divided between those viewing the pullback as a generational value opportunity given the stock's massive buyback program, and skeptics who fear that long-term AI disruption and a shift toward a freemium model threaten the company's competitive moat.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is trending as investors react to positive Phase 1 clinical data for subcutaneous Briumvi in myasthenia gravis and a concurrent initiation of a Phase 2 trial. The stock is seeing high social media volume fueled by speculation about a potential buyout and community optimism regarding Briumvi's expanding market potential.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is experiencing high volatility as investors rotate capital from existing space sector proxies into the long-awaited SpaceX public market debut. While community sentiment remains split between concerns over short-term liquidity outflows and strong conviction in upcoming satellite launch catalysts, market participants are actively debating whether this pullback represents a major accumulation opportunity or a broader de-rating of the sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Viking Therapeutics Appoints Hubert Chen As Chief Medical Officer

(RTTNews) - Viking Therapeutics, Inc. (VKTX), a clinical-stage biopharmaceutical company, Thursday announced that it has appointed Hubert Chen, as its Chief Medical Officer...

Viking Therapeutics Announces Appointment of Hubert C. Chen, M.D., as Chief Medical Officer

Viking Therapeutics Announces Appointment of Hubert C. Chen, M.D., as Chief Medical Officer Viking Therapeutics Announces Appointment of Hubert C. Chen, M.D., as Chief Medical Officer PR Newswire SAN DIEGO, June 11, 2026 Experienced Biotech Leader with More than Two Decades of Experience Advancing...

Viking Therapeutics, Inc. (VKTX) Falls More Steeply Than Broader Market: What Investors Need to Know

In the latest trading session, Viking Therapeutics, Inc. (VKTX) closed at $27.73, marking a -5.13% move from the previous day.

Why 1 Wall Street Analyst Thinks Viking Therapeutics Stock Could Soar 188%

Key PointsThe global market for drugs that treat obesity could be worth $150 billion by 2035...

Inside the GLP-1 Boom: ETF Picks for the Obesity Drug Market

GLP-1 drugs are reshaping healthcare and consumer markets. These ETFs offer targeted exposure to the booming obesity-drug trend.

Can Eli Lilly's Clinical Momentum Keep the Stock at Record Highs?

LLY stock hits a new all-time high as data from phase III studies show Foundayo outperforming rivals and retatrutide delivering strong weight-loss and diabetes results.

Can Wegovy Pill's Rapid Uptake Give Novo Nordisk an Edge Over LLY?

NVO's oral Wegovy launch is off to a blistering start, topping 3 million prescriptions in five months and drawing many first-time GLP-1 users.

Can Eli Lilly's 2026 Acquisition Spree Diversify Growth Beyond GLP-1s?

LLY's 2026 deal-making spree spans vaccines, oncology and neuroscience, aiming to diversify growth beyond GLP-1s amid rising obesity competition.

LLY Rises 14% in a Month: Should You Hold as Obesity Growth Continues?

Eli Lilly stock gains 14% in a month as strong Q1 results, obesity drug coverage expansion and promising retatrutide data fueled momentum. 

Bull vs. Bear: The Quick Take on Viking Therapeutics Stock

Key PointsEli Lilly and Novo Nordisk are much larger companies and already have oral weight loss pills on the market...

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

VKTXViking Therapeutics Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest VKTX News